FDA approves Teva's generic EpiPen after yearslong delay
TEVA: Announces FDA Approval of AJOVY® (fremanezumab-vfrm) Injection Autoinjector | FDA Health News
Medincell stock drops as FDA hits Teva with CRL on long-acting risperidone | BioWorld
The Latest Breaking News from Teva Pharmaceutical Industries Ltd – inkl news
Teva recalls US-made drugs following contamination fears - The Boston Globe
Teva and MedinCell Announce FDA Approval of UZEDY™ (risperidone) Extended-Release Injectable Suspension, a Long-Acting Subcutaneous Atypical Antipsychotic Injection, for the Treatment of Schizophrenia in Adults | Business Wire
Teva Announces Approval of a Generic Version of Forteo® (teriparatide injection), in the U.S.
Teva shares rally as FDA approves troubled drugmaker's migraine treatment | The Times of Israel
Teva Prepares To Launch LAI Risperidone After US Approval :: Generics Bulletin
Pharma News | Bristol Myers Squibb, Teva, MedinCell, Biogen
Teva Issues Voluntary Nationwide Recall of One Lot of Anagrelide Capsules | DAIC
FDA Approves Teva's Generic Version of EpiPen Injector - WSJ
Teva Earns First FDA Approval for Generic Drug for Major Depressive Disorder | 2019-10-10 | FDAnews
Teva Wins FDA Approval for Digital Inhaler Combining Powder with Sensors, App
UPDATED: Teva's struggling sterile plant hit with FDA warning letter | Fierce Pharma
FDA Confirms Nationwide Adderall Shortage After Weeks of Reported Backlogs
Teva's troubled Godollo plant earns firm US FDA warning letter
Teva Announces FDA Approval of ProAir RespiClick - Drug Discovery and Development
Israeli Tech and Innovation News - NoCamels
Teva Pharmaceuticals USA, Inc., Issues Voluntary Nationwide Recall of Specific Lots of Fentanyl Buccal Tablets CII Because of Labeling Error | ONS Voice
Teva Pharmaceuticals and MedinCell gain FDA approval for UZEDY, the first subcutaneous, long-acting formulation of risperidone for the treatment of schizophrenia in adults.
Teva Pharmaceuticals gets FDA approval for Osteoporosis injection | Eric A. Hughes, MD, PhD posted on the topic | LinkedIn
Regeneron and Teva's fasinumab hit with FDA clinical hold | Fierce Biotech
